A review of available long-term follow-up data presents clinical and hemodynamic outcomes 2-5 years after TAVI, including published cases of prosthesis degeneration.
Does transcatheter aortic valve implantation (TAVI) improve long-term clinical outcomes and valve durability in patients at high risk or contraindicated for cardiac surgery?
This review summarizes the available clinical and hemodynamic data regarding long-term outcomes and valve durability 2-5 years after TAVI.
Transcatheter aortic valve implantation (TAVI) is a widely used intervention in patients who are at high risk or contraindicated for cardiac surgery. The procedure is technically feasible in most patients and has very good mid-term clinical outcomes. In this special report, we evaluated the long-term outcome after TAVI and durability of percutaneously implanted aortic valve prostheses by reviewing all available long-term follow-up data. We herein present the clinical and hemodynamic data derived from patients 2-5 years after TAVI and describe all published cases of prosthesis degeneration.
Sulženko et al. (Wed,) conducted a review in Aortic valve disease in patients at high risk or contraindicated for cardiac surgery. Transcatheter aortic valve implantation (TAVI) was evaluated on Long-term clinical outcome and valve durability. A review of available long-term follow-up data presents clinical and hemodynamic outcomes 2-5 years after TAVI, including published cases of prosthesis degeneration.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: